Drug intelligence / Profile preview

bCalm

Development stage
Phase 4
Lead developer
NuLife Sciences
Modality
Small Molecules
Administration
Oral
01

Overview

**bCalm** is a NuLife Sciences oral nutraceutical dietary supplement marketed under the company's microvascular health and wellness portfolio, but the product-specific positioning identified in the provided context is for emotional health rather than a defined microvascular indication. The active ingredient is reported to correspond 100% to **inositol**, commonly described in supplement marketing as vitamin B8, and it is promoted to calm the mind and body naturally and support tranquility and overall wellness. Mechanistically, bCalm appears to function as an **inositol supplement** rather than a pharmaceutical drug with a validated single molecular target; any anxiolytic or metabolic effects would be attributed to inositol's role as an endogenous carbohydrate involved in phosphoinositide and second-messenger signaling, but no specific clinical development program or drug pipeline evidence was identified for bCalm.

Brand names
bCalm
Other names
inositolvitamin B8
02

Targets

SLC5A11 (Sodium-coupled myo-inositol transporter 2 (SMIT2))SLC2A13 (Proton myo-inositol cotransporter (HMIT1))SLC5A3 (Sodium/myo-inositol cotransporter 1 (SMIT1))

Beyond the preview

Go deeper on bCalm.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on bCalm.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call